Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 10-k point of interest
Our cash and short-term marketable securities balances increased from approximately $6,265,000 as of May 31, 2009 to approximately $10,352,000 as of May 31, 2010. We also have restricted cash balances amounting to approximately $52,000 as of May 31, 2009 and approximately $21,000 as of May 31, 2010. Total current assets increased from approximately $8,065,000 as of May 31, 2009 to approximately $13,417,000 as of May 31, 2010. Total current liabilities amounted to approximately $1,034,000 and approximately $942,000 as of May 31, 2009 and May 31, 2010, respectively. The change in our current position as of May 31, 2010 as compared with May 31, 2009 results primarily from the redemption of $6.1 million in par value of our ARS securities during the fiscal year 2010 and our note receivable issuances during the fiscal ended May 31, 2010.
4
Aug 16, 2010 05:27PM
4
Aug 16, 2010 05:37PM

Aug 16, 2010 08:53PM
Share
New Message
Please login to post a reply